These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15669685)

  • 21. p.L18P: a novel IDUA mutation that causes a distinct attenuated phenotype in mucopolysaccharidosis type I patients.
    Pasqualim G; Ribeiro MG; da Fonseca GG; Szlago M; Schenone A; Lemes A; Rojas MV; Matte U; Giugliani R
    Clin Genet; 2015 Oct; 88(4):376-80. PubMed ID: 25256405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mutant stop codon (TAG) in the IDUA gene is used as an acceptor splice site in a patient with Hurler syndrome (MPS IH).
    Tieu PT; Menon K; Neufeld EF
    Hum Mutat; 1994; 3(3):333-6. PubMed ID: 8019572
    [No Abstract]   [Full Text] [Related]  

  • 23. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
    Malm G; Gustafsson B; Berglund G; Lindström M; Naess K; Borgström B; von Döbeln U; Ringdén O
    Acta Paediatr; 2008 Aug; 97(8):1108-12. PubMed ID: 18452566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
    Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
    Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy.
    Pereira VG; Martins AM; Micheletti C; D'Almeida V
    Clin Chim Acta; 2008 Jan; 387(1-2):75-9. PubMed ID: 17920576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychosocial outcomes of bone marrow transplant for individuals affected by Mucopolysaccharidosis I Hurler Disease: patient social competency.
    Pitt C; Lavery C; Wager N
    Child Care Health Dev; 2009 Mar; 35(2):271-80. PubMed ID: 19228160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The presenting features of mucopolysaccharidosis type IH (Hurler syndrome).
    Cleary MA; Wraith JE
    Acta Paediatr; 1995 Mar; 84(3):337-9. PubMed ID: 7780260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A deletion/insertion mutation in the IDUA gene in a Libyan Jewish patient with Hurler syndrome (mucopolysaccharidosis IH).
    Moskowitz SM; Tieu PT; Neufeld EF
    Hum Mutat; 1993; 2(1):71-3. PubMed ID: 8477267
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mutation analysis and prenatal diagnosis of 2 cases with mucopolysaccharidosis type I].
    Wang XN; Wei M; Shi HP; Qiu ZQ; Yao FX; Meng Y; Zhang WM
    Zhonghua Er Ke Za Zhi; 2011 Apr; 49(4):306-10. PubMed ID: 21624210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties.
    Wraith JE
    J Inherit Metab Dis; 2001 Apr; 24(2):245-50. PubMed ID: 11405343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations.
    Beesley CE; Meaney CA; Greenland G; Adams V; Vellodi A; Young EP; Winchester BG
    Hum Genet; 2001 Nov; 109(5):503-11. PubMed ID: 11735025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of 30 mucopolysaccharidosis type I patients: evaluation of the mutational spectrum in Italian population and identification of 13 novel mutations.
    Venturi N; Rovelli A; Parini R; Menni F; Brambillasca F; Bertagnolio F; Uziel G; Gatti R; Filocamo M; Donati MA; Biondi A; Goldwurm S
    Hum Mutat; 2002 Sep; 20(3):231. PubMed ID: 12203999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic strategy of mucopolysaccharidosis type I in Tunisia].
    Chkioua L; Ferchichi S; Khedhiri S; Laradi S; Bibi A; Amira D; Dandana A; Ben Mansour R; Ben Limam H; Chaabouni M; Froissart R; Maire I; Miled A
    Ann Biol Clin (Paris); 2007; 65(2):175-9. PubMed ID: 17353172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation analysis of 19 North American mucopolysaccharidosis type I patients: identification of two additional frequent mutations.
    Clarke LA; Nelson PV; Warrington CL; Morris CP; Hopwood JJ; Scott HS
    Hum Mutat; 1994; 3(3):275-82. PubMed ID: 8019563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation.
    Yamada Y; Kato K; Sukegawa K; Tomatsu S; Fukuda S; Emura S; Kojima S; Matsuyama T; Sly WS; Kondo N; Orii T
    Bone Marrow Transplant; 1998 Mar; 21(6):629-34. PubMed ID: 9543069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mutation analysis of 11 Chinese patients with attenuated mucopolysaccharidosis type].
    WANG XN; SHI HP; ZHANG WM; QIU ZQ; MENG Y; YAO FX; WEI M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Apr; 28(2):147-51. PubMed ID: 21462124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme replacement therapy in 12 patients with MPS I-H/S with homozygous p.Leu490Pro mutation.
    Arora RS; Mercer J; Thornley M; Tylee K; Wraith JE
    J Inherit Metab Dis; 2007 Oct; 30(5):821. PubMed ID: 17570076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for degradation of mRNA encoding alpha-L-iduronidase in Hurler fibroblasts with premature termination alleles.
    Menon KP; Neufeld EF
    Cell Mol Biol (Noisy-le-grand); 1994 Nov; 40(7):999-1005. PubMed ID: 7849567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.
    Scott HS; Bunge S; Gal A; Clarke LA; Morris CP; Hopwood JJ
    Hum Mutat; 1995; 6(4):288-302. PubMed ID: 8680403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p.X654R IDUA variant among Thai individuals with intermediate mucopolysaccharidosis type I and its residual activity as demonstrated in COS-7 cells.
    Ngiwsara L; Ketudat-Cairns JR; Sawangareetrakul P; Charoenwattanasatien R; Champattanachai V; Kuptanon C; Pangkanon S; Tim-Aroon T; Wattanasirichaigoon D; Svasti J
    Ann Hum Genet; 2018 May; 82(3):150-157. PubMed ID: 29282708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.